HealthTech Member:



Dr. Dan Daly - CEO and Dr. Robin Taylor CTO, talk to Eagle Labs HealthTech about Occuity.

Tell us about Occuity.

Occuity aims to revolutionise the way in which some of the world’s most prevalent chronic diseases are detected and managed. Our devices work by harmlessly shining a low power beam of light into the eye, collecting and analysing the return signal and are unlike anything else on the market.

Our novel, internationally patented non-contact technology accurately detects changes in the eye and will thereby derive information not only about a patient’s ocular health, but also about their broader wellbeing, particularly where this relates to chronic, life changing conditions.

We are developing a range of handheld devices aimed at some of the major health problems of our time. Due to the size of the market, we are particularly interested in addressing diabetes by developing products to enable earlier diagnosis and will enable non-contact, pain-free glucose monitoring.

Our first product, however, will be a Pachymeter, a handheld device for opticians to measure the thickness of the cornea. The prototype is at the point of undergoing clinical trials and is due to be ready for sale early in 2022. Following on from this will be more advanced meters to screen first for diabetes then for Alzheimer’s Disease, then a personal blood glucose meter for people with diabetes.

When did you start your business?


What's been your biggest highlight?

Growing the company in the space of just two years from two founders to a highly experienced team of 35 experts and getting our first product ready for market.

What's been your biggest challenge?

Maintaining the required momentum during COVID - lock downs, supply chain issues etc.

Advice for entrepreneurs starting out

Surround yourself with people who are smarter than you are.

Share this page

Go back to the top of the page